[
  {
    "ts": "2025-10-07T15:20:00+00:00",
    "headline": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
    "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
    "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f9e031e4-803b-3103-83ca-4e000d143ba0",
      "content": {
        "id": "f9e031e4-803b-3103-83ca-4e000d143ba0",
        "contentType": "STORY",
        "title": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
        "description": "",
        "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
        "pubDate": "2025-10-07T15:20:00Z",
        "displayTime": "2025-10-07T15:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "DataM Intelligence 4 Market Research LLP Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tAyZzQodmbAzF2vHT0G.Dg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gVv0fgg5FCouR0nL5tGSQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "4502.T"
            },
            {
              "symbol": "SRPT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-07T12:27:00+00:00",
    "headline": "Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?",
    "summary": "MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.",
    "url": "https://finance.yahoo.com/news/merck-rises-13-week-buy-122700121.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6078dda0-cea6-388d-852f-65028ee9908f",
      "content": {
        "id": "6078dda0-cea6-388d-852f-65028ee9908f",
        "contentType": "STORY",
        "title": "Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.",
        "pubDate": "2025-10-07T12:27:00Z",
        "displayTime": "2025-10-07T12:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A9LQHlDmqgPJbKsotfjd8w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5.ym16dSp_UIlCHMRMZUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-rises-13-week-buy-122700121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-rises-13-week-buy-122700121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-07T08:44:00+00:00",
    "headline": "3 Dividend Stocks to Double Up On Right Now",
    "summary": "The time is right for buying more of these great dividend stocks.",
    "url": "https://www.fool.com/investing/2025/10/07/3-dividend-stocks-to-double-up-on-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "b5485db4-8348-39a3-9be0-7b23118af4c7",
      "content": {
        "id": "b5485db4-8348-39a3-9be0-7b23118af4c7",
        "contentType": "STORY",
        "title": "3 Dividend Stocks to Double Up On Right Now",
        "description": "",
        "summary": "The time is right for buying more of these great dividend stocks.",
        "pubDate": "2025-10-07T08:44:00Z",
        "displayTime": "2025-10-07T08:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fb4eea0eb9f2caa742f829d13e64c3ed",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Coca-Cola bottles.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3ickzKS01nHWRunlARPRjQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/fb4eea0eb9f2caa742f829d13e64c3ed.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5X48YMXRmE83PYItBAJ2vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fb4eea0eb9f2caa742f829d13e64c3ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/07/3-dividend-stocks-to-double-up-on-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-stocks-double-now-084400530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "EPD"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]